Clinical trial

Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS-C/D)

NCT04922008

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-07-01

PhasePHASE2

Study timeline

Study start (estimated)2021-07-01Date precision: day

Registry last updated2021-06-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

capecitabine and trastuzumabDRUG

vinorelbine and trastuzumabDRUG

Sponsors & collaborators

Fudan Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04922008 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.